RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 47 filers reported holding RECRO PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $440,319 | +17.1% | 938,847 | +174.5% | 0.05% | +24.3% |
| Q2 2023 | $376,160 | -17.9% | 341,964 | -11.2% | 0.04% | -21.3% |
| Q1 2023 | $458,432 | -49.4% | 385,237 | -36.6% | 0.05% | -58.4% |
| Q4 2022 | $905,422 | +129.8% | 607,666 | +151.7% | 0.11% | +105.5% |
| Q3 2022 | $394,000 | +99.0% | 241,472 | -2.8% | 0.06% | +111.5% |
| Q2 2022 | $198,000 | -58.8% | 248,472 | -6.9% | 0.03% | -52.7% |
| Q1 2022 | $481,000 | -7.7% | 266,972 | -12.3% | 0.06% | -3.5% |
| Q4 2021 | $521,000 | +644.3% | 304,533 | +793.0% | 0.06% | +5600.0% |
| Q3 2021 | $70,000 | -11.4% | 34,103 | -0.9% | 0.00% | -90.0% |
| Q2 2021 | $79,000 | -76.1% | 34,403 | -70.9% | 0.01% | -76.7% |
| Q1 2021 | $330,000 | +148.1% | 118,232 | +153.3% | 0.04% | +126.3% |
| Q4 2020 | $133,000 | -36.1% | 46,682 | +83.5% | 0.02% | -60.4% |
| Q1 2020 | $208,000 | – | 25,438 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
| First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
| AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
| Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
| HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
| Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
| Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
| TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
| ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |